Evidence map›Paper›PMID 17425651›Full record

ArticleClinical and experimental immunology2007

Smoking and a complement gene polymorphism interact in promoting cardiovascular disease morbidity and mortality.

G J Arason, J Kramer, B Blaskó, R Kolka, P Thorbjornsdottir, K Einarsdóttir, A Sigfúsdóttir, S T Sigurdarson, G Sigurdsson, Z Rónai and 5 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Clinical and experimental immunology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. The state of complement in COVID-19.Nature reviews. Immunology · 2022
    Review
  4. Article
  5. Review
  6. Glycogen synthase kinase 3 beta gene structural variants as possible risk factors of bipolar depression.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2014
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

G J ArasonDepartment of Immunology, Institute for Medical Laboratory Sciences, Landspítali University Hospital, Reykjavík, Iceland. garason@lsh.is
J Kramer
B Blaskó
R Kolka
P Thorbjornsdottir
K Einarsdóttir
A Sigfúsdóttir
S T Sigurdarson
G Sigurdsson
Z Rónai
Z Prohászka
M Sasvári-Székely
S Bödvarsson
G Thorgeirsson
G Füst
National University Hospital of Iceland · ISSemmelweis University · HUHungarian Academy of Sciences · HUJahn Ferenc Dél-Pesti Kórház és Rendelőintézet · HUReykjavík University · IS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We have demonstrated previously that carriers of a genotype called C4B*Q0 (silent allele of the C4B gene) have a substantially increased risk to suffer from myocardial infarction or stroke, and are selected out from the healthy elderly population. Because smoking carries a major risk for cardiovascular disease (CVD), it seemed worthwhile to study if these two factors interact. Study 1 involved 74 patients with angina pectoris (AP), 85 patients with recent acute myocardial infarction (AMI) and 112 survivors of a previous AMI and 382 controls from Iceland. Study 2 involved 233 patients with severe CVD and 274 controls from Hungary. Smoking habits were registered for each subject. The number of C4A and C4B genes was determined by phenotyping or genotyping. Compared to controls, C4B*Q0 carrier frequency was significantly higher at diagnosis in Icelandic smokers with AP (P = 0.005) and AMI (P = 0.0003) and Hungarian smokers with severe coronary artery disease (P = 0.023), while no such difference was observed in non-smoking subjects. Age-associated decrease in C4B*Q0 observed previously in two remote Caucasian populations was found, in the present study, to be associated strongly with smoking, and to already occur in smokers after age 50 years both in Iceland and Hungary. Our findings indicate that the C4B*Q0 genotype can be considered as a major covariate of smoking in precipitating the risk for AMI and associated deaths.

Indexed as

Polymorphism, GeneticAdolescentAdultAgedAged, 80 and overAngina PectorisCardiovascular DiseasesComplement C4bFemaleGenetic Predisposition to DiseaseGenotypeHumansMaleMiddle AgedMyocardial InfarctionPhenotypeComplement C4b

Identifiers

PMID17425651
PMCPMC1942025
OpenAlexW1509510202

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.